[rev_slider alias=”new-activities” /]
Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) is a non-profit scientific organisation, founded in 2000 with the mission to perform research and education in the life sciences, biotechnologies, and pharmaceutical fields. Its main focus is drug development for small populations (paediatric and rare diseases).
Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) mission is to enhance technology-driven paediatric research in drug discovery and early development phases to be translated into clinical research. CVBF promotes networking within the scientific community and collaboration between stakeholders to harness efficiency of the European research infrastructures and delivery of research services. CVBF
supports adequate policies pushing towards higher scientific, ethical and societal standards for a better implementation of health systems and allocation of resources. CVBF activities are organised within two operational areas Development&Networking and Clinical Research.
Latest News
SAVE THE DATE: “Pharmacovigilance: common assessment tools and Promoter responsibility – 25 June 2019, Rome
On 25 June 2019, a workshop entitled “ Pharmacovigilance: common assessment tools and Promoter responsibility” will be held at University Polyclinic “Agostino Gemelli” in Rome. Dr. Mariagrazia Felisi, Clinical Research Director at Consorzio per Valutazioni [...]
Newsletter, June 2024
Dear Reader, Imagine a world where every child, regardless of their condition, has access to safe, effective, and child-friendly therapies. This vision has been the driving force behind CVBF since its inception in 2000. Our [...]
RACE Act accelerates Paediatric Oncology Drug Testing, FDA reports
The U.S. Food and Drug Administration (FDA) has reported a significant increase in the number of planned studies to test drugs for pediatric cancers, thanks to the Research Acceleration for Cure and Equity (RACE) for [...]
